January 4, 1994 |
SPI Pharmaceuticals Inc., a subsidiary of ICN Pharmaceuticals Inc., on Monday announced plans to buy 30% of a state-owned drug manufacturer in Hungary for an undisclosed amount. Completion of the transaction awaits approval by the Hungarian government. The company, Alkaloida, makes about 60 products--including medicinal morphine, antacids and treatments for asthma--sold in 80 countries. It is based in Tiszavasvari, Hungary, and employs 2,100 people.